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Abstract
Ability to quantify and predict progression of a disease is fundamental for selecting
an appropriate treatment. Many clinical metrics cannot be acquired frequently ei-
ther because of their cost (e.g. MRI, gait analysis) or because they are inconvenient
or harmful to a patient (e.g. biopsy, x-ray). In such scenarios, in order to esti-
mate individual trajectories of disease progression, it is advantageous to leverage
similarities between patients, i.e. the covariance of trajectories, and find a latent
representation of progression. Most of existing methods for estimating trajectories
do not account for events in-between observations, what dramatically decreases
their adequacy for clinical practice. In this study, we develop a machine learning
framework named Coordinatewise-Soft-Impute (CSI) for analyzing disease pro-
gression from sparse observations in the presence of confounding events. CSI is
guaranteed to converge to the global minimum of the corresponding optimization
problem. Experimental results also demonstrates the effectiveness of CSI using
both simulated and real dataset.
1 Introduction
The course of disease progression in individual patients is one of the biggest uncertainties in medical
practice. In an ideal world, accurate, continuous assessment of a patient’s condition helps with
prevention and treatment. However, many medical tests are either harmful or inconvenient to perform
frequently, and practitioners have to infer the development of disease from sparse, noisy observations.
In its simplest form, the problem of modeling disease progressions is to fit the curve of y(t), t ∈
[tmin, tmax] for each patient, given sparse observations y := (y(t1), . . . , y(tn)). Due to the high-
dimensional nature of longitudinal data, existing results usually restrict solutions to subspace of
functions and utilize similarities between patients via enforcing low-rank structures. One popular
approach is the mixed effect models, including Gaussian process approaches [13, 14] and functional
principal components [4]. While generative models are commonly used and have nice theoretical
properties, their result could be sensitive to the underlying distributional assumptions of observed
data and hard to adapt to different applications. Another line of research is to pose the problem of
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disease progression estimation as an optimization problem. Kidzinski and Hastie. [5] proposed a
framework which formulates the problem as a matrix completion problem and solves it using matrix
factorization techniques. This method is distribution-free and flexible to possible extensions.
Meanwhile, both types of solutions model the natural progression of disease using observations of
the targeted variables only. They fail to incorporate the existence and effect of human interference:
medications, therapies, surgeries, etc. Two patients with similar symptoms initially may have different
futures if they choose different treatments. Without that information, predictions can be way-off.
To the best of our knowledge, existing literature talks little about modeling treatment effect on
disease progression. In [5], authors use concurrent observations of auxillary variables (e.g. oxygen
consumption to motor functions) to help estimate the target one, under the assumption that both
variables reflect the intrinsic latent feature of the disease and are thus correlated. Treatments of
various types, however, rely on human decisions and to some extent, an exogenous variable to the
development of disease. Thus they need to be modeled differently.
In this work, we propose a model for tracking disease progression that includes the effects of
treatments. We introduce the Coordinatewise-Soft-Impute (CSI) algorithm for fitting the model and
investigate its theoretical and practical properties. The contribution of our work is threefold: First,
we propose a model and an algorithm CSI, to estimate the progression of disease which incorporates
the effect of treatment events. The framework is flexible, distribution-free, simple to implement
and generalizable. Second, we prove that CSI converges to the global solution regardless of the
initialization. Third, we compare the performance of CSI with various other existing methods on both
simulated data and a dataset of Gillette Children’s Hospital with patients diagnosed with Cerebral
Palsy, and demonstrate the superior performances of CSI.
The rest of the paper is organized as follows. In Section 2 we state the problem and review existing
methods. Next, in Section 3 we describe the model and the algorithm. Theoretic properties of the
algorithm are derived in Section 4. Finally, in Section 5 and 6 we provides empirical results of CSI
on the simulated and the real datesets respectively. We discuss some future directions in Section 7.
2 Problem statement and related work
Let y(t) be the trajectory of our objective variable, such as the size of tumor, over fixed time range
t ∈ [tmin, tmax], and N be the number of patients. For each patient 1 ≤ i ≤ N , we measure
its trajectory yi(t) at ni irregularly time points ti = [ti,1, ti,2, ..., ti,ni ]
′ and denote the results as
yi = [yi,1, ..., yi,ni ]
′ = [yi(ti,1), ..., yi(ti,ni)]
′. We are primarily interested in estimating the disease
progression trajectories {yi(t)}Ni=1 of all N patients, based on observation data {(ti,yi)}Ni=1.
To fit a continuous curve based on discrete observations, we restrict our estimations to a finite-
dimensional space of functions. Let {bi, i ∈ N} be a fixed basis of L2([tmin, tmax]) (e.g. splines,
Fourier basis) and b = {bi : 1 ≤ i ≤ K} be first K components of it. The problem of estimating
yi(t) can then be reduced to the problem of estimating the coefficients wi = [wi,1, wi,2, · · · , wi,K ]′
such that w′ib(t) is close to yi(t) at time t ∈ ti.
When the number of observations per patient is less than or equal to the number of basis functions K,
we can perfectly fit any curve without error, leading to overfitting. Moreover, this direct approach
ignores the similarities between curves. Below we describe two main lines of research improving on
this, the mixed-effect model and the matrix completion model.
2.1 Linear mixed-effect model
In mixed-effect models, every trajectory yi(t) is assumed to be composed of two parts: the fixed
effect µ(t) = m′b(t) for some m ∈ RK that remains the same among all patients and a random
effect wi ∈ RK that differs for each i ∈ {1, . . . , N}. In its simplest form, we assume
wi ∼ N (0,Σ) and yi|wi ∼ N (µi +Biwi, σ2Ini),
where Σ is the K × K covariance matrix, σ is the standard deviation and µi =
[µ(ti,1), µ(ti,2), · · ·µ(ti,ni)]′, Bi = [b(ti,1),b(ti,2), · · · ,b(ti,ni)]′ are functions µ(t) and b(t) eval-
uated at the times ti, respectively. Estimations of model parameters µ,Σ can be made via expectation
maximization (EM) algorithm [6]. Individual coefficientswi can be estimated using the best unbiased
linear predictor (BLUP) [3].
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In linear mixed-effect model, each trajectory is estimated with |wi| = K degrees of freedom, which
can still be too complex when observations are sparse. One typical solution is to assume a low-rank
structure of the covariance matrix Σ by introducing a contraction mapping A from the functional
basis to a low-dimensional latent space. More specifically, one may rewrite the LMM model as
yi|w˜i ∼ N (µi +BiAw˜i, σ2Ini),
where A is aK×q matrix with q < K and w˜i ∈ Rq is the new, shorter random effect to be estimated.
Methods based on low-rank approximations are widely adopted and applied in practice and different
algorithms on fitting the model have been proposed [4, 7, 11]. In the later sections, we will compare
our algorithm with one specific implementation named functional-Principle-Component-Analysis
(fPCA) [4], which uses EM algorithm for estimating model parameters and latent variables wi.
2.2 Matrix completion model
While the probabilistic approach of mixed-effect models offers many theoretical advantages including
convergence rates and inference testing, it is often sensitive to the assumptions on distributions, some
of which are hard to verify in practice. To avoid the potential bias of distributional assumptions in
mixed-effect models, Kidzinski et al. in [5] formulate the problem as a sparse matrix completion
problem. We will review this approach in the current section.
To reduce the continuous-time trajectories into matrices, we discretize the time range [tmin, tmax]
into T equi-distributed points G = [τ1, . . . , τT ] with τ1 = tmin, τT = tmax and let B =
[b(τ1),b(τ2), · · · ,b(τT )]′ ∈ RT×K be the projection of the K-truncated basis b onto grid G.
The N ×K observation matrix Y is constructed from the data {(ti,yi)}Ni=1 by rounding the time ti,j
of every observation yi(ti,j) to the nearest time grid and regarding all other entries as missing values.
Due to sparsity, we assume that no two observation yi(ti,j)’s are mapped to the same entry of Y .
Let Ω denote the set of all observed entries of Y . For any matrix A, let PΩ(A) be the projection of
A onto Ω, i.e. PΩ(A) = M where Mi,j = Ai,j for (i, j) ∈ Ω and Mi,j = 0 otherwise. Similarly,
we define P⊥Ω (A) = A− PΩ(A) to be the projection on the complement of Ω. Under this setting,
the trajectory prediction problem is reduced to the problem of fitting a N ×K matrix W such that
WB′ ≈ Y on observed indices Ω.
The direct way of estimating W is to solve the optimization problem
arg min
W
1
2
‖PΩ(Y −WB′)‖2F , (2.1)
where ‖ · ‖F is the Fröbenius norm. Again, if K is larger than the number of observations for some
subject we will overfit. To avoid this problem we need some additional constraints on W . A typical
approach in the matrix completion community is to introduce a nuclear norm penalty—a relaxed
version of the rank penalty while preserving convexity [10, 2]. The optimization problem with the
nuclear norm penalty takes form
arg min
W
1
2
‖PΩ(Y −WB′)‖2F + λ‖W‖∗, (2.2)
where λ > 0 is the regularization parameter, ‖ · ‖F is the Fröbenius norm, and ‖ · ‖∗ is the nuclear
norm, i.e. the sum of singular values. In [5], a Soft-Longitudinal-Impute (SLI) algorithm is proposed
to solve (2.2) efficiently. For completeness of the paper, we include the SLI algorithm in Appendix
A, while noting that it is also a special case of our algorithm 1 defined in the next section with µ fixed
to be 0.
3 Modeling treatment in disease progression
In this section, we introduce our model on effect of treatments in disease progression.
A wide variety of treatments with different effects and durations exist in medical practice and it
is impossible to build a single model to encompass them all. In this study we take the simplified
approach and regard treatment, with the example of one-time surgery in mind, as a non-recurring
event with an additive effect on the targeted variable afterward. Due to the flexibility of formulation of
optimization problem (2.1), we build our model based on matrix completion framework of Section 2.2.
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More specifically, let s(i) ∈ G be the time of treatment of the i’th patient, rounded to the closest
τk ∈ G (s(i) =∞ if no treatment is performed). We encode the treatment information as a N × T
zero-one matrix IS , where (IS)i,j = 1 if and only τj ≥ s(i), i.e. patient i has already taken the
treatment by time τj . Each row of IS takes the form of (0, · · · , 0, 1, · · · , 1). Let µ denote the average
additive effect of treatment among all patients. In practice, we have access to the sparse observation
matrix Y and surgery matrix IS and aim to estimate the treatment effect µ and individual coefficient
matrix W based on Y, IS and the fixed basis matrix B such that WB′ + µIS ≈ Y .
Again, to avoid overfitting and exploit the similarities between individuals, we add a penalty term on
the nuclear norm of W . The optimization problem is thus expressed as:
arg min
µ,W
1
2
‖PΩ(Y −WB′ − µIS)‖2F + λ‖W‖∗, (3.1)
for some λ > 0.
3.1 Coordinatewise-Soft-Impute (CSI) algorithm
Though the optimization problem (3.1) above does not admit an explicit analytical solution, it is
not hard to solve for one of µ or W given the other one. For fixed µ, the problem reduces to the
optimization problem (2.2) with Y˜ = Y −µIS and can be solved iteratively by the SLI algorithm [5],
which we will also specify later in Algorithm 1. For fixed W , we have
arg min
µ
1
2
‖PΩ(Y −WB′ − µIS)‖2F + λ‖W‖∗
= arg min
µ
1
2
‖PΩ(−WB′ − µIS)‖2F = arg min
µ
1
2
∑
(i,j)∈Ω∩ΩS
((Y −WB′)i,j − µ)2, (3.2)
where ΩS is the set of non-zero indices of IS . Optimization problem (3.2) can be solved by taking
derivative with respect to µ directly, which yields
µˆ =
∑
(i,j)∈Ω∩ΩS (Y −WB′)i,j
|Ω ∩ ΩS | . (3.3)
The clean formulation of (3.3) motivates us to the following Coordinatewise-Soft-Impute (CSI)
algorithm (Algorithm 1): At each iteration, CSI updates Wnew from (Wold, µold) via soft singular
value thresholding and then updates µnew from (Wnew, µold) via (3.3), finally it replaces the missing
values of Y based (Wnew, µnew). In the definition, we define operator Sλ as for any matrix X ,
Sλ(X) := UDλV , where X = UDV is the SVD of X and Dλ = diag((max{di − λ, 0})Ki=1) is
derived from the diagonal matrix D = diag((di)Ki=1). Note that if we set µ ≡ 0 throughout the
updates, then we get back to our base model SLI without treatment effect.
Algorithm 1: COORDINATEWISE-SOFT-IMPUTE
1. Initialize Wold ← all-zero matrix, µold ← 0.
2. Repeat:
(a) Compute Wnew ← Sλ((PΩ(Y − µoldIS) + P⊥Ω (WoldB′))B);
(b) Compute µnew ←
∑
(i,j)∈Ω∩ΩS (Y−WnewB
′)i,j
|Ω∩ΩS | ;
(c) If max
{
(µnew−µold)2
µ2old
,
‖Wnew−Wold‖2F
‖Wold‖2F
}
< ε, exit;
(d) Assign Wold ←Wnew, µold ← µnew.
3. Output Wˆλ ←Wnew, µˆλ ← µnew.
4 Convergence Analysis
In this section we study the convergence properties of Algorithm 1. Fix the regularization parameter
λ > 0, let (µ(k)λ ,W
(k)
λ ) be the value of (µ,W ) in the k’th iteration of the algorithm, the exact
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definition of which is provided below in (4.4). We prove that Algorithm 1 reduces the loss function at
each iteration and eventually converges to the global minimizer.
Theorem 1. The sequence (µ(k)λ ,W
(k)
λ ) converges to a limit point (µˆλ, Wˆλ) which solves the opti-
mization problem:
(µˆλ, Wˆλ) = arg min
µ,W
1
2
‖PΩ(Y −WB′ − µIS)‖2F + λ‖W‖∗.
Moreover, (µˆλ, Wˆλ) satisfies that
Wˆλ = Sλ((PΩ(Y − µˆλIS) + P⊥Ω (WˆλB′))B), µˆλ =
∑
(i,j)∈Ω∩ΩS (Y − WˆλB′)i,j
|Ω ∩ ΩS | . (4.1)
The proof of Theorem 1 relies on five technique Lemmas stated below. The detailed proofs of
the lemmas and the proof to Theorem 1 are provided in Appendix B. The first two lemmas are on
properties of the nuclear norm shrinkage operator Sλ defined in Section 3.1.
Lemma 1. Let W be an N × K matrix and B is an orthogonal T × K matrix of rank K. The
solution to the optimization problem minW 12‖Y −WB′‖2F + λ‖W‖∗ is given by Wˆ = Sλ(Y B)
where Sλ(Y B) is defined in Section 3.1.
Lemma 2. Operator Sλ(·) satisfies the following inequality for any two matrices W1, W2 with
matching dimensions:
‖Sλ(W1)− Sλ(W2)‖2F ≤ ‖W1 −W2‖2F .
Define
fλ(W,µ) =
1
2
‖PΩ(Y −WB′ − µIS)‖2F + λ‖W‖∗, (4.2)
Qλ(W |W˜ , µ) = 1
2
‖PΩ(Y − µIS) + P⊥Ω (W˜B′)−WB′‖2F + λ‖W‖∗. (4.3)
Lemma 1 shows that in the k-th step of Algorithm 1, W (k) is the minimizer for function
Q(·|W (k−1), µ(k)). The next lemma proves the sequence of loss functions fλ(W (k)λ , µ(k)λ ) is mono-
tonically decreasing at each iteration.
Lemma 3. For every fixed λ ≥ 0, the k’th step of the algorithm (µ(k)λ ,W (k)λ ) is given by
W
(k)
λ = arg minW
Qλ(W |W (k−1)λ , µ(k−1)λ ) µ(k)λ =
∑
(i,j)∈Ω∩ΩS (Y −W
(k)
λ B
′)i,j
|Ω ∩ ΩS | . (4.4)
Then with any starting point (µ(0)λ ,W
(0)
λ ), the sequence {(µ(k)λ ,W (k)λ )}k satisfies
fλ(W
(k)
λ , µ
(k)
λ ) ≤ fλ(W (k)λ , µ(k−1)λ ) ≤ Qλ(W (k)λ |W (k−1)λ , µ(k−1)λ ) ≤ fλ(W (k−1)λ , µ(k−1)λ ).
The next lemma proves that differences (µk − µk−1)2 and ‖W (k)λ −W (k−1)λ ‖2F both converge to 0.
Lemma 4. For any positive integer k, we have ‖W (k+1)λ − W (k)λ ‖2F ≤ ‖W (k)λ − W (k−1)λ ‖2F .
Moreover,
µ
(k+1)
λ − µ(k)λ → 0, W (k+1λ −W (k)λ → 0 as k →∞.
Finally we show that if the sequence {(µ(k)λ ,W (k)λ )}k, it has to converge to a solution of (4.1).
Lemma 5. Any limit point (µˆλ, Wˆλ) of sequences {(µ(k)λ ,W (k)λ )}k satisfies (4.1).
5 Simulation study
In this section we illustrate properties of our Coordinatewise-Soft-Impute (CSI) algorithm via
simulation study. The simulated data are generated from a mixed-effect model with low-rank
covariance structure on W :
Y = WB + µIS + E ,
for which the specific construction is deferred to Appendix C. Below we discuss the evaluation
methods as well as the results from simulation study.
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5.1 Methods
We compare the Coordinatewise-Soft-Impute (CSI) algorithm specified in Algorithm 1 with the
vanilla algorithm SLI (corresponding to µˆ = 0 in our notation) defined in [5] and the fPCA algorithm
defined in [4] based on mixed-effect model. We train all three algorithms on the same set of basis
functions and choose the tuning parameters λ (for CSI and SLI) and R (for fPCA) using a 5-fold
cross-validation. Each model is then re-trained using the whole training set and tested on a held-out
test set Ωtest consisting 10% of all data.
The performance is evaluated in two aspects. First, for different combinations of the treatment effect µ
and observation density ρ, we train each of the three algorithms on the simulated data set, and compute
the relative squared error between the ground truth µ and estimation µˆ., i.e., RSE(µˆ) = (µˆ− µ)2/µ2.
Meanwhile, for different algorithms applied to the same data set, we compare the mean square error
between observation Y and estimation Yˆ over test set Ωtest, namely,
MSE(Yˆ ) =
1
|Ωtest|
∑
(i,j)∈Ωtest
(Yij − Yˆij)2 = 1|Ωtest| ‖PΩtest(Y )− PΩtest(Yˆ )‖
2
F (5.1)
We train our algorithms with all combinations of treatment effect µ ∈ {0, 0.2, 0.4, · · · , 5}, obser-
vation rate ρ ∈ {0.1, 0.3, 0.5}, and thresholding parameter λ ∈ {0, 1, · · · , 4} (for CSI or SLI) or
rank R ∈ {2, 3, · · · , 6} (for fPCA). For each fixed combination of parameters, we implemented each
algorithm 10 times and average the test error.
5.2 Results
The results are presented in Table 1 and Figure 1. From Table 1 and the left plot of Figure 1, we have
the following findings:
1. CSI achieves better performance than SLI and fPCA, regardless of the treatment effect µ
and observation rate ρ. Meanwhile SLI performs better than fPCA.
2. All three methods give comparable errors for smaller values of µ. In particular, our introduc-
tion of treatment effect µ does not over-fit the model in the case of µ = 0.
3. As the treatment effect µ increases, the performance of CSI remains the same whereas
the performances of SLI and fPCA deteriorate rapidly. As a result, CSI outperforms SLI
and fPCA by a significant margin for large values of µ. For example, when ρ = 0.1, the
MSE(Yˆ ) of CSI decreases from 72.3% of SLI and 59.6% of fPCA at µ = 1 to 12.4% of
SLI and 5.8% of fPCA at µ = 5.
4. All three algorithms suffer a higher MSE(Yˆ ) with smaller observation rate ρ. The biggest
decay comes from SLI with an average 118% increase in test error from ρ = 0.5 to
ρ = 0.1. The performances of fPCA and CSI remains comparatively stable among different
observation rate with a 6% and 12% increase respectively. This implies that our algorithm is
tolerant to low observation rate.
To further investigate CSI’s ability to estimate µ, we plot the relative squared error of µˆ using CSI
with different observation rate in the right plot of Figure 1. As shown in Figure 1, regardless of the
choice of observation rate ρ and treatment effect µ, RSE(µˆ) is always smaller than 1% and most of
the estimations achieves error less than 0.1%. Therefore we could conclude that, even for sparse
matrix Y , the CSI algorithm could still give very accurate estimate of the treatment effect µ.
Observation rate ρ 0.1 0.3 0.5
Treatment effect µ 1 2 5 1 2 5 1 2 5
MSE(Y )
fPCA 0.521 2.172 5.455 0.525 2.039 5.170 0.525 2.036 5.166
SLI 0.430 1.162 2.561 0.379 0.658 1.203 0.341 0.543 0.893
CSI 0.311 0.306 0.318 0.314 0.297 0.320 0.294 0.299 0.295
Table 1: Comparisons between fPCA, SLI and CSI under different values of ρ and µ.
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Figure 1: Left: Comparisons between fPCA, SLI and CSI in estimating Y with different obser-
vation rates. Lines with colors red, green and blue correspond to fPCA, SLI and CSI respectively.
Dotted, dashed and straight lines correspond to observation rate ρ = 0.1, 0.3 and 0.5 respectively.
Right: Relationship between relative squared error of µˆ and treatment effect µ using CSI with
different observation rate. Lines with colors red, green and blue correspond to observation rate
ρ = 0.1, 0.3 and 0.5 respectively.
6 Data Study
In this section, we apply our methods to real dataset on the progression of motor impairment and gait
pathology among children with Cerebral Palsy (CP) and evaluate the effect of orthopaedic surgeries.
Cerebral palsy is a group of permanent movement disorders that appear in early childhood. Or-
thopaedic surgery plays a major role in minimizing gait impairments related to CP [9]. However, it
could be hard to correctly evaluate the outcome of a surgery. For example, the seemingly positive
outcome of a surgery may actually due to the natural improvement during puberty. Our objective is
to single out the effect of surgeries from the natural progression of disease and use that extra piece of
information for better predictions.
6.1 Data and Method
We analyze a data set of Gillette Children’s Hospital patients, visiting the clinic between 1994
and 2014, age ranging between 4 and 19 years, mostly diagnosed with Cerebral Palsy. The data
set contains 84 visits of 36 patients without gait disorders and 6066 visits of 2898 patients with
gait pathologies. Gait Deviation Index (GDI), one of the most commonly adopted metrics for gait
functionalities [12], was measured and recorded at each clinic visit along with other data such as
birthday, subtype of CP, date and type of previous surgery and other medical results.
Our main objective is to model individual disease progression quantified as GDI values. Due to
insufficiency of data, we model surgeries of different types and multiple surgeries as a single additive
effect on GDI measurements following the methodology from Section 3. We test the same three
methods CSI, SLI and fPCA as in Section 5, and compare them to two benchmarks—the population
mean of all patients (pMean) and the average GDI from previous visits of the same patient (rMean).
All three algorithms was trained on the spline basis of K = 9 dimensions evaluated at a grid
of T = 51 points, with regularization parameters λ ∈ {20, 25, ..., 40} for CSI and SLI and rank
constraints r ∈ {2, . . . , 6} for fPCA. To ensure sufficient observations for training, we cross validate
and test our models on patients with at least 4 visits and use the rest of the data as a common training
set. The effective size of 2-fold validation sets and test set are 5% each. We compare the result of
each method/combination of parameters using the mean square error of GDI estimations on held-out
entries as defined in (5.1).
6.2 Results
We run all five methods on the same training/validation/test set for 40 times and compare the mean
and sd of test-errors. The results are presented in Table 2 and Figure 2. Compared with the null model
pMean (Column 2 of Table 2), fPCA gives roughly the same order of error; CSI, SLI and rowMean
provide better predictions, achieving 62%, 66% and 73% of the test errors respectively. In particular,
our algorithm CSI improves the result of vanilla model SLI by 7%, it also provide a stable estimation
with the smallest sd across multiple selections of test sets.
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mean scaled mean sd
CSI 74.28 0.62 8.90
SLI 79.92 0.66 9.22
fPCA 127.73 1.06 13.54
rMean 87.26 0.73 8.96
pMean 119.80 1.00 12.84
Table 2: Test error on GDI dataset Figure 2: Box plot for test errors
(a) Top 3 PCs from CSI algorithm (b) Predicted curve of patient ID 5416
Figure 3: Low-rank decomposition of disease progression curves
We take a closer look at the low-rank decomposition of disease progression curves provided by
algorithms. Fix one run of algorithm CSI with λ? = 30, there are 6 non-zero singular value vectors,
which we will refer as principal components. We illustrate the top 3 PCs scaled with corresponding
singular values in Figure 3a. The first PC recovers the general trend that gait disorder develops
through age 1-10 and partially recovers during puberty. The second and third PC reflects fluctuations
during different periods of child growth. By visual inspection, similar trends can be find in the top
components of SLI and fPCA as well.
An example of predicted curve from patient ID 5416 is illustrated in Figure 3b , where the blue curve
represents the prediction without estimated treatment effect µˆ = 4.33, green curve the final prediction
and red dots actual observations. It can be seen that the additive treatment effect helps to model the
sharp difference between the exam before exam (first observation) and later exams.
7 Conclusion and Future Work
In this paper, we propose a new framework in modeling the effect of treatment events in disease
progression and prove a corresponding algorithm CSI. To the best of our knowledge, it’s the first
comprehensive model that explicitly incorporates the effect of treatment events. We would also like
to mention that, although we focus on the case of disease progression in this paper, our framework is
quite general and can be used to analyze data in any disciplines with sparse observations as well as
external effects.
There are several potential extensions to our current framework. Firstly, our framework could be
extended to more complicated settings. In our model, treatments have been characterized as the
binary matrix IS with a single parameter µ. In practice, each individual may take different types
of surgeries for one or multiple times. Secondly, the treatment effect may be correlated with the
latent variables of disease type, and can be estimated together with the random effect wi. Finally, our
framework could be used to evaluate the true effect of a surgery. A natural question is: does surgery
really help? CSI provides estimate of the surgery effect µ, it would be interesting to design certain
statistical hypothesis testing procedure to answer the proposed question.
Though we are convinced that our work will not be the last word in estimating the disease progression,
we hope our idea is useful for further research and we hope the readers could help to take it further.
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A Soft-Longitudinal-Impute (SLI) algorithm
Algorithm 2: SOFT-LONGITUDINAL-IMPUTE
1. Initialize W old ← all-zero matrix.
(a) Repeat:
i. Compute W new ← Sλ((PΩ(Y ) + P⊥Ω (W oldB′))B)
ii. If ‖W
new−W old‖2F
‖W old‖2F
< ε exit
iii. Assign W old ←W new
2. Output Wˆλ ←W new
B Proofs
Proof of Lemma 1. Note that the solution of the optimization problem
min
A
1
2
‖Z −A‖2F + λ‖A‖∗ (B.1)
is given by Aˆ = Sλ(Z) (see [1] for a proof). Therefore it suffices to show the minimizer of the
optimization problem (B.1) is the same as the minimizer of the following problem:
min
W
1
2
‖Y B −W‖2F + λ‖W‖∗.
Using the fact that ‖A‖2F = Tr(AA′) and B′B = IK , we have
arg min
W
1
2
‖Y B −W‖2F + λ‖W‖∗ = arg min
W
1
2
(Tr(Y BB′Y ′) + Tr(WW ′)− 2Tr(Y BW ′)) + λ‖W‖∗
= arg min
W
1
2
(Tr(WW ′)− 2Tr(Y BW ′)) + λ‖W‖∗.
On the other hand
arg min
W
1
2
‖Y −WB′‖2F + λ‖W‖∗ = arg min
W
1
2
(Tr(Y Y ′) + Tr(WW ′)− 2Tr(Y BW ′)) + λ‖W‖∗
= arg min
W
1
2
(Tr(WW ′)− 2Tr(Y BW ′)) + λ‖W‖∗
= arg min
W
1
2
‖Y B −W‖2F + λ‖W‖∗
= Sλ(Y B),
as desired.
Proof of Lemma 2. We refer the readers to the proof in [8, Section 4, Lemma 3].
Proof of Lemma 3. First we argue that µ(k)λ = arg minµ fλ(W
(k)
λ , µ) and the first inequality imme-
diately follows. We have
arg min
µ
fλ(W
(k)
λ , µ) = arg minµ
‖PΩ(Y −W (k)λ B′ − µIS)‖2F
= arg min
µ
∑
(i,j)∈Ω∩ΩS
((Y −W (k)λ B′)i,j − µ)2.
Taking derivative with respect to µ directly gives µ(k)λ = arg minµ fλ(W
(k)
λ , µ), as desired.
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For the rest two inequalities, notice that
fλ(W
(k)
λ , µ
(k−1)
λ ) =
1
2
‖PΩ(Y −W (k)λ B′ − µ(k−1)λ IS)‖2F + λ‖W (k)λ ‖∗
≤ 1
2
‖PΩ(Y − µ(k−1)λ IS) + P⊥Ω (W (k−1)λ B′)−W (k)λ B′‖2F + λ‖W (k)λ ‖∗ (B.2)
= Qλ(W
(k)
λ |W (k−1)λ , µ(k−1)λ )
≤ Qλ(W (k−1)λ |W (k−1)λ , µ(k−1)λ ) (B.3)
=
1
2
‖PΩ(Y −W (k−1)λ B′ − µ(k−1)λ IS)‖2F + λ‖W (k−1)λ ‖∗
= fλ(W
(k−1)
λ , µ
(k−1)
λ ).
Here the (B.2) holds because we have
1
2
‖PΩ(Y − µ(k−1)λ IS) + P⊥Ω (W (k−1)λ B′)−W (k)λ B′‖2F
=
1
2
‖PΩ(Y − µ(k−1)λ IS −W (k)λ B′) + P⊥Ω (W (k−1)λ B′ −W (k)λ B′)‖2F
=
1
2
‖PΩ(Y − µ(k−1)λ IS −W (k)λ B′)‖2F +
1
2
‖P⊥Ω (W (k−1)λ B′ −W (k)λ B′)‖2F
≥1
2
‖PΩ(Y − µ(k−1)λ IS −W (k)λ B′)‖2F .
(B.3) follows from the fact that W (k)λ = arg minW Qλ(W |W (k−1)λ , µ(k−1)λ ).
Proof of Lemma 4. First we analyze the behavior of {µ(k)λ },
fλ(W
(k)
λ , µ
(k−1)
λ )− fλ(W (k)λ , µ(k)λ ) =
1
2
‖PΩ(Y −W (k)λ B′ − µ(k−1)λ IS)‖2F
− 1
2
‖PΩ(Y −W (k)λ B′ − µ(k)λ IS)‖2F
=
|S ∩ ΩS |
2
(µ
(k)
λ − µ(k−1)λ )2.
Meanwhile, the sequence (· · · , fλ(W (k−1)λ , µ(k−1)λ ), fλ(W (k)λ , µ(k−1)λ ), fλ(W (k)λ , µ(k)λ ), · · · ) is de-
creasing and lower bounded by 0 and therefore converge to a non-negative number, yielding the
differences fλ(W
(k)
λ , µ
(k−1)
λ )− fλ(W (k)λ , µ(k)λ )→ 0 as k →∞. Hence
µ
(k)
λ − µ(k−1)λ → 0, (B.4)
as desired.
The sequence {W (k)λ } is slightly more complicated, direct calculation gives
‖W (k)λ −W (k−1)λ ‖2F = ‖Sλ(PΩ(Y − µ(k−1)λ IS) + P⊥Ω (W (k−1)λ B′))
− Sλ(PΩ(Y − µ(k−2)λ IS) + P⊥Ω (W (k−2)λ B′))‖2F
≤ ‖PΩ(Y − µ(k−1)λ IS) + P⊥Ω (W (k−1)λ B′) (B.5)
− PΩ(Y − µ(k−2)λ IS)− P⊥Ω (W (k−2)λ B′)‖2F
= |Ω ∩ ΩS |(µ(k−1)λ − µ(k−2)λ )2 + ‖P⊥Ω (W (k−1)λ B′ −W (k−2)λ B′)‖2F , (B.6)
where (B.5) follows from Lemma 2, (B.6) can be derived pairing the 4 terms according to PΩ and
P⊥Ω .
By definition of µ(k)λ , we have
|Ω ∩ ΩS |(µ(k−1)λ − µ(k−2)λ )2 =
1
|Ω ∩ ΩS |
 ∑
(i,j)∈Ω∩ΩS
(W
(k−1)
λ B
′ −W (k−2)λ B′)i,j
2
≤ ‖PΩ(W (k−1)λ B′ −W (k−2)λ B′)‖2F , (B.7)
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where (B.7) follows from the Cauchy-Schwartz inequality.
Combining (B.6) with (B.7), we get
‖W (k)λ −W (k−1)λ ‖2F ≤ ‖W (k−1)λ B′ −W (k−2)λ B′‖2F = ‖W (k−1)λ −W (k−2)λ ‖2F .
Now we are left to prove that the difference sequence {W (k)λ −W (k−1)λ } converges to zero. Combining
(B.4) and (B.7) it suffices to prove that ‖P⊥Ω (W (k−1)λ B′ −W (k−2)λ B′)‖2F → 0. We have
fλ(W
(k−1)
λ , µ
(k−2)
λ )−Qλ(W (k−1)λ |W (k−2)λ , µ(k−2)λ ) = −‖P⊥Ω (W (k−1)λ B′ −W (k−2)λ B′)‖2F ,
and the left hand side converges to 0 because
0 ≥ fλ(W (k−1)λ , µ(k−2)λ )−Qλ(W (k−1)λ |W (k−2)λ , µ(k−2)λ )
≥ fλ(W (k−2)λ , µ(k−2)λ )− fλ(W (k−1)λ , µ(k−2)λ )→ 0,
which completes the proof.
Proof of Lemma 5. Let (µmkλ ,W
mk
λ ) → (µˆλ, Wˆλ), then Lemma 4 gives (µmk−1λ ,Wmk−1λ ) →
(µˆλ, Wˆλ). Since we have
W
(mk)
λ = Sλ((PΩ(Y − µ(mk−1)λ IS) + P⊥Ω (W (mk−1)λ B′))B),
µ
(mk)
λ =
∑
(i,j)∈Ω∩ΩS (Y −W
(mk−1)
λ B
′)i,j
|Ω ∩ ΩS | .
Taking limits on both sides gives us the desire result.
Proof of Theorem 1. Let (µˆλ, Wˆλ) be one limit point then we have:
‖Wˆλ −W (k)λ ‖F = ‖Sλ((PΩ(Y − µˆλIS) + P⊥Ω (WλB′))B) (B.8)
− Sλ((PΩ(Y − µˆ(k−1)λ IS) + P⊥Ω (W (k−1)λ B′))B)‖2F
≤ |Ω ∩ ΩS |(µˆλ − µ(k−1)λ )2 + ‖P⊥Ω ((Wˆλ −W (k−1)λ )B′)‖2F , (B.9)
here (B.8) uses Lemma 5 and (B.9) uses Lemma 2. Meanwhile,
|Ω ∩ ΩS |(µˆλ − µ(k−1)λ )2 =
∑
(i,j)∈Ω∩ΩS ((Wˆλ −W
(k−1)
λ )B
′)2i,j
|Ω ∩ ΩS | ≤ ‖PΩ((Wˆλ −W
(k−1)
λ )B
′)‖2F .
(B.10)
Combining (B.9) and (B.10), we have
‖Wˆλ −W (k)λ ‖F ≤ ‖Wˆλ −W (k−1)λ ‖F .
Hence the sequence ‖Wˆλ −W (k)λ ‖F is monotonically decreasing and has a limit. But since there
exists W (mk)λ converging to Wˆλ, the limit equals 0, which proves W
(k)
λ → Wˆλ, µ(k)λ → µˆ.
Therefore we have proved the sequence (µ(k)λ ,W
(k)
λ ) always converges. Meanwhile, notice that the
loss function fλ(W,µ) is a convex function with respect to (W,µ) and Lemma 3 guarantees that the
sequence fλ(W
(k)
λ , µ
(k)
λ ) converges. Thus we have proved that the pair (µ
(k)
λ ,W
(k)
λ ) minimizes the
function fλ(W,µ).
C Data generation
Let G be the grid of T equidistributed points and let B be the basis of K spline functions evaluated
on grid G. We will simulate the N ×K observation matrix Y with three parts
Y = WB + µIS + E ,
where W follows a mixture-Gaussian distribution with low rank structure, IS is the treatment matrix
with uniformly distributed starting time and E represents the i.i.d. measurement error. The specific
procedures is described below.
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1. Generating W given parameters κ ∈ (0, 1), r1, r2 ∈ R, s1, s2 ∈ RK≥0:
(a) Sample two K ×K orthogonal matrices V1, V2 via singular-value-decomposing two
random matrix.
(b) Sample two unit length K vectors ~γ1, ~γ2 via normalizing i.i.d. normal samples.
(c) Draw vector ~t ∈ RN from i.i.d. Bernoulli(κ) samples. Denote the all one vector by ~1.
(d) Draw N ×K matrices U1, U2 from i.i.d. standard normal random variables.
(e) Set
W ← ~t ·
[
r1~γ1 + U1 diag[
√
s1]V1
]
+ (~1− ~t) ·
[
r2~γ2 + U2 diag[
√
s2]V2
]
,
where diag[s] is the diagonal matrix with diagonal elements s, “·” represents coordi-
natewise multiplication, and we are recycling ~t,~1− ~t and ri~γi to match the dimension.
2. Generating IS given parameter ptr ∈ (0, 1).
(a) For each k = 1, . . . , N , sample Tk uniformly at random from {1, . . . , bT/ptrc}.
(b) Set IS ← (1{j ≥ Ti})1≤i≤N,1≤j≤T .
3. Given parameter  ∈ R≥0, E is drawn from from i.i.d. Normal(0, 2) samples.
4. Given parameter µ ∈ R, let Y0 ←WB + µIS + E .
5. Given parameter ρ ∈ (0, 1), drawn 0-1 matrix IΩ from i.i.d. Bernoulli(ρ) samples. Let Ω
denote the set of non-zero entries of IΩ, namely, the set of observed data. Set
Y ← (Yij)1≤i≤N,1≤j≤T , where Yij =
{
(Y0)ij if (IΩ)ij = 1
NA otherwise
.
In actual simulation, we fix the auxiliary parameters as follows,
K = 7, T = 51, N = 500,
κ = 0.33, r1 = 1, r2 = 2,
s1 = [1, 0.4, 0.005, 0.1 exp(−3), ..., 0.1 exp(−K + 1)],
s2 = [1.3, 0.2, 0.005, 0.1 exp(−3), ..., 0.1 exp(−K + 1)],
ptr = 0.8,  = 0.5.
The remaining parameters are treatment effect µ and observation rate ρ, which we allow to vary
across different trials.
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